Provided by Tiger Fintech (Singapore) Pte. Ltd.

First Advantage Corp.

16.81
+0.35002.13%
Post-market: 16.810.00000.00%16:21 EDT
Volume:678.47K
Turnover:11.32M
Market Cap:2.92B
PE:-17.64
High:16.82
Open:16.51
Low:16.28
Close:16.46
Loading ...

Biogen’s New Study on Omaveloxolone for Young FA Patients: Market Insights

TIPRANKS
·
15 Jul

Bitcoin Hits Record High for Consecutive Days, Hong Kong Stock Crypto Concept Stocks and ETFs Soar

Blockbeats
·
11 Jul

Solid Biosciences Announces FDA IND and Health Canada CTA Approval for First-in-Class Cardiac Gene Therapy to Treat Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

GlobeNewswire
·
09 Jul

Larimar Therapeutics’ nomlabofusp shows therapeutic potential in FA

TIPRANKS
·
08 Jul

Larimar Therapeutics Publishes Nonclinical Data Supporting the Therapeutic Potential of Nomlabofusp in Patients with Friedreich’s Ataxia

GlobeNewswire
·
08 Jul

Lexeo Therapeutics Announces FDA Breakthrough Therapy Designation for LX2006 in Friedreich Ataxia

GlobeNewswire
·
07 Jul

Nine's Streaming Unit Agrees to Acquire Telecommunications Firm's Rights to Premier League, Emirates FA Cup

MT Newswires Live
·
30 Jun

Corpay Inc. Appoints Peter Walker as New Chief Financial Officer, Effective July 2025

Reuters
·
11 Jun

Director Clark James Lindsey Reports Disposal of Common Shares of First Advantage Corporation

Reuters
·
11 Jun

First Advantage Holds 2025 Annual Stockholders Meeting

TIPRANKS
·
10 Jun

First Advantage Corporation Concluded Annual Stockholders Meeting

Reuters
·
10 Jun

First Advantage Corporation President Joelle M. Smith Reports Disposal of Common Shares

Reuters
·
05 Jun

Design Therapeutics announces first FA patient dosed in RESTORE-FA trial

TIPRANKS
·
04 Jun

Cautious Hold on First Advantage: Balancing Promising Growth with Short-term Challenges

TIPRANKS
·
02 Jun

J.P. Morgan Remains a Buy on First Advantage (FA)

TIPRANKS
·
31 May

William Blair Sticks to Their Buy Rating for First Advantage (FA)

TIPRANKS
·
30 May

First Advantage Is Maintained at Equal-Weight by Barclays

Dow Jones
·
29 May

Fountain Asset Corp. Reports Improved Q1 2025 Financial Results

TIPRANKS
·
28 May

Press Release: Lexeo Therapeutics Announces $80 Million Equity Financing to Further Advance Development of Transformative Genetic Medicines for Cardiovascular Diseases

Dow Jones
·
27 May

First Advantage Corporation to Participate in William Blair Growth Stock Conference in Chicago

Reuters
·
20 May